PDF) Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: A Hellenic Cooperative Oncology Group (HeCOG) study
Leprosy Reactivation and Lepromatous Gangrene Associated with Chemotherapy for Advanced Gastric Cancer: A Case Report and Review of the Literature - | Semantic Scholar
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group | SpringerLink
Vol 4, No 14 (July 2016) - Annals of Translational Medicine
PDF) Recent advances in diagnostic technologies in lung cancer
PDF) An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with
Table of Contents page: Journal of Thoracic Oncology
International Manual of Oncology Practice | SpringerLink
PDF) 144PCyclin D1 differential activation and its prognostic impact among advanced breast cancer patients treated with trastuzumab
World Journal of Surgical Oncology Reviewer Acknowledgement 2013 – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
PDF) Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia
Cancers | Free Full-Text | A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First-
PDF) Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton
Cancers | Free Full-Text | A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First-
PDF) Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy
PDF) Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: Real-world data from
PDF) Current and Emerging Roles of Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small Cell Lung Cancer
PDF) Mitogen-Activated Protein Kinase Activation in Lung Adenocarcinoma: A Comparative Study between Ever Smokers and Never Smokers
PDF) Excision Repair Cross Complementation Group 1 Immunohistochemical Expression Predicts Objective Response and Cancer-Specific Survival in Patients Treated by Cisplatin-Based Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell ...
PDF) Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy
Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer - Urology
Lung Cancer in Greece - Journal of Thoracic Oncology
PDF) Adrenal Incidentalomas in Cancer Patients Are Not Always “Innocent”: A Case Report and Review of the Literature
Table of Contents page: Journal of Thoracic Oncology
PDF) Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: The experience of the Hellenic
Table of Contents page: Journal of Thoracic Oncology
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group | SpringerLink
Table of Contents page: Journal of Thoracic Oncology
